BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35991009)

  • 1. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.
    Lertpanprom M; Silsirivanit A; Tippayawat P; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():835914. PubMed ID: 35991009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients.
    Aung TM; Ciin MN; Silsirivanit A; Jusakul A; Lert-Itthiporn W; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():836985. PubMed ID: 35392474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma.
    Tummanatsakun D; Proungvitaya T; Roytrakul S; Limpaiboon T; Wongkham S; Wongkham C; Silsirivanit A; Somintara O; Sangkhamanon S; Proungvitaya S
    Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31454981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.
    Janan M; Proungvitaya S; Limpaiboon T; Proungvitaya T; Roytrakul S; Wongkham C; Jearanaikoon P; Chur-in S; Wongkham S
    Asian Pac J Cancer Prev; 2012; 13 Suppl():107-14. PubMed ID: 23480771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.
    Boonjaraspinyo S; Boonmars T; Wu Z; Loilome W; Sithithaworn P; Nagano I; Pinlaor S; Yongvanit P; Nielsen PS; Pairojkul C; Khuntikeo N
    Tumour Biol; 2012 Oct; 33(5):1785-802. PubMed ID: 22733151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
    Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
    Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B
    Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma.
    Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
    Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
    Zhou Z; Ma J
    Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
    Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
    Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.
    Zhang X; Yang Z; Shi Z; Zhu Z; Li C; Du Z; Zhang Y; Wang Z; Jiao Z; Tian X; Zhang J; Zhai W; Kan Q
    J Steroid Biochem Mol Biol; 2021 Jan; 205():105775. PubMed ID: 33130021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of PTPRM predicts poor prognosis and promotes tumor growth and lymph node metastasis in cervical cancer.
    Liu P; Zhang C; Liao Y; Liu J; Huang J; Xia M; Chen M; Tan H; He W; Xu M; Liu T; Ooi S; Du Q; Qin S; Zhu Y; Zou Q; Wang W; Yao S
    Cell Death Dis; 2020 Aug; 11(8):687. PubMed ID: 32826853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
    Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
    Chang TT; Ho CH
    PLoS One; 2020; 15(8):e0238251. PubMed ID: 32845921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.
    Chua-On D; Proungvitaya T; Techasen A; Limpaiboon T; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sungkhamanon S; Proungvitaya S
    Tumour Biol; 2016 Oct; 37(10):13659-13667. PubMed ID: 27473083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
    Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.